Biofidus AG is a leading brand in the field of (bio)analytical services, specializing in protein-based drugs and therapies. Founded in 2015 by Dr. Benjamin Müller and a team of experienced scientists, Biofidus aims to offer a holistic service platform to meet the analytical challenges faced by the pharmaceutical industry.

With a strong network and decades of expertise, Biofidus has grown into a medium-sized company with 22 experts dedicated to providing high-quality and reliable services. Biofidus offers a comprehensive range of services, including but not limited to protein sequence analysis, impurity analysis, aggregation analysis, and charge heterogeneity analysis. They also provide services for small molecules, spent media, metabolites, vitamins, and neurotransmitter technologies.

Their cutting-edge technologies such as LC-ESI-MS/MS peptide mapping, capillary gel electrophoresis, and nanopore DNA/RNA sequencing enable them to deliver accurate and precise results. With a focus on customer satisfaction, Biofidus constantly invests in technology and experts to stay at the forefront of the industry. Their commitment to innovation and their exceptional track record make them a trusted partner for pharmaceutical companies seeking expert bioanalytical solutions.

Contact Biofidus AG today to accelerate your development and overcome your bioanalytical challenges